NCT03794895

Brief Summary

Studying the efficacy of uterine artery doppler in predicting response to mefenamic acid in women having IUCD associated menorrhagia

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 27, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 7, 2019

Completed
Last Updated

January 7, 2019

Status Verified

January 1, 2019

Enrollment Period

1 year

First QC Date

December 27, 2018

Last Update Submit

January 3, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Resistance index and Pulsitality index (Predicting the response to IUCD associated menorrhagia)

    Base line uterine artery doppler is done to the patient complaining of IUCD related menorrhagia prior to treatment , parameters of doppler are: resistance index and pulsitality index, then the patient takes mefenamic acid tablets 500 mg three times daily for five days, assessment of response whether the patient is responder or not is done using pictorial blood loss assessment chart then base line doppler parameters in responders and non responders are compared to correlate the response to base line doppler parameters

    1 year

Study Arms (1)

Single arm clinical trial

EXPERIMENTAL
Device: Doppler

Interventions

DopplerDEVICE

Doing doppler for women having IUCD associated menorrhagia

Single arm clinical trial

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsfemale having menorrhagia due to IUCD
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • women in chile bearing period (age 20-35 yrs ) with history of regular menstrual cycle presenting with recent onset of more then three months menorrhagia after IUCD "copper T 380 A" insertion

You may not qualify if:

  • history of bleeding tendency
  • history of abnormal uterine bleeding due to other causes
  • history of active liver disease
  • history of antiplatelet or anticoagulant intake in the last month
  • history of thyroid disease
  • history of endometritis
  • history of allergy to NSAIDs
  • Adenomyosis
  • women having contraindications to use NSAIDs e.g. peptic ulcer
  • Insulin dependant diabetes mellitus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AinshamsU

Cairo, Abbaseya, 11511, Egypt

Location

MeSH Terms

Conditions

Dysmenorrhea

Interventions

Echocardiography, Doppler

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

EchocardiographyCardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonographyUltrasonography, DopplerHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Officials

  • Yasmine Es Ismail, Bachelor

    Ain Shams University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 27, 2018

First Posted

January 7, 2019

Study Start

May 1, 2017

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

January 7, 2019

Record last verified: 2019-01

Locations